We noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Introduction (2)
- Problems with current risk factors
- Effects of risk factors on CVD mortality
- Prediction of CHD in diabetes
- Oxidative stress and cardiovascular risk
- Molecular consequences of oxidative stress
- The polygenic nature of CHD
- Gene environment interaction
- Genes load the gun, environment pulls the trigger
- Genetic & biochemical markers of oxidative stress
- Aim of this presentation
- Measurement of oxidative stress
- Plasma Total Antioxidant Status (TAOS)
- Mitochondrial uncoupling protein 2
- A novel antioxidant UCP2 ?
- Mitochondria are major source of cellular ROS
- UCL-diabetes and cardiovascular disease study
- Northwick park heart study II
- Prospective CHD risk by plasma TAOS in NPHSII
- UCP2 common variants
- Plasma TAOS and UCP2 -866G>A genotype
- Oxidative stress and UCP2 -866G>A genotype
- Plasma TAOS, smoking, and UCP2 -866G>A
- UCP2 genotype and CHD risk in NPHSII
- Other CHD risk factors
- The important of UCP2
- UCP2 environment interaction and CHD risk
- Does statin treatment reduce oxidative stress?
- Apolipoprotein E (APOE)
- APOE and CHD risk
- APOE genotype and CHD risk
- APOE and oxidative stress
- The APOE genotype interaction with smoking
- Glutathione s-transferase gene (GST)
- GSTs and oxidative stress
- The role of glutathione s-transferase
- GST gene variants
- GST gene variants and CVD
- Plasma Ox-LDL by GSTT1 genotype & smoking
- Other gene variants (1)
- Other gene variants (2)
- Summary overview
- Acknowledgments
Topics Covered
- Oxidative stress: a risk factor for CVD
- Biochemical markers of oxidative stress
- Genetic determinants of oxidative stress: examples
- Examples of gene-environment interaction in determining oxidative stress and CVD
- Other gene variants and oxidative stress
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Stephens, J. (2008, November 24). Gene-environment interaction and oxidative stress in cardiovascular disease [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 3, 2024, from https://doi.org/10.69645/QYWF3240.Export Citation (RIS)
Publication History
Financial Disclosures
- Dr. Jeffrey Stephens has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
Gene-environment interaction and oxidative stress in cardiovascular disease
A selection of talks on Cardiovascular & Metabolic
Hide